hsa-miR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Title
hsa-miR-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Authors
Keywords
-
Journal
CANCER
Volume -, Issue -, Pages NA-NA
Publisher
Wiley
Online
2010-02-25
DOI
10.1002/cncr.25009

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started